Article Details

Stifel initiates Beam Therapeutics [BEAM] at Hold rating with $84 price target

Retrieved on: 2021-01-06 13:41:15

Tags for this article:

Click the tags to see associated articles and topics

Stifel initiates Beam Therapeutics [BEAM] at Hold rating with $84 price target. View article details on hiswai:

Excerpt

Details in the latest 13F filings reveal that Hillhouse Capital Advisors Ltd. disposed of their 0.00% stake valued at $148,320,150 while The Vanguard ...

Article found on: marketglobalist.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo